HSBC Holdings plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K, dated July 5, 2024, reports a transaction in own shares by HSBC Holdings plc. The filing details share repurchases executed on July 5, 2024, as part of a buy-back program announced on May 7, 2024.
Key Financial Metrics
The filing focuses on capital return activities rather than operational financial performance. Key metrics include:
- UK Venues Repurchase: 7,632,897 shares purchased at a volume-weighted average price of £6.7642 (range: £6.7080 - £6.8560).
- Hong Kong Stock Exchange Repurchase: 2,997,200 shares purchased at a volume-weighted average price of HK$68.4478 (range: HK$67.9500 - HK$69.2000).
- Cumulative Buy-back (since May 7, 2024): 286,820,352 ordinary shares repurchased for a total consideration of approximately US$2,512.5 million.
- Issued Share Capital: Following the cancellation of UK repurchases, issued ordinary share capital stands at 18,562,081,308 shares. No shares are held in treasury.
The filing does not provide data on revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
The primary material change is the reduction in issued share capital due to the cancellation of repurchased shares on UK venues. The total number of voting shares has decreased to 18,562,081,308. Cancellation of shares repurchased on the Hong Kong Stock Exchange is pending and will be announced separately.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future outlook, or discussion of risks and contingencies. It is a statutory disclosure of a completed transaction.
Investor Verification Checklist
- Verify the updated denominator for shareholder interest calculations (18,562,081,308 shares) for UK-based holdings.
- Monitor future announcements for the final cancellation of shares repurchased on the Hong Kong Stock Exchange to confirm the total global share count.
- Review the full trade breakdown available via the London Stock Exchange link provided in the filing for granular transaction details.
- Confirm the total cumulative spend of US$2,512.5 million against the company's broader capital allocation strategy.